CP-866087 - AN OVERVIEW

bortezomib will increase the level or outcome of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Improved flibanserin adverse effects may well take place if coadministered with various weak CYP3A4 inhibitors.B: Might be appropriate. Both animal research demonstrate no threat but human scientific studies no